Lou DeLoureiro, VP, US Access and Analytics
If access change only becomes visible after utilization moves, you’re already late.
Most market access teams still rely on signals designed to explain the past, such as published policies, observed shares, and retrospective models. Meanwhile, payers keep adjusting access through operational levers that do not show up in a policy update for weeks or months. The result is a growing gap between declared access and the experience of prescribers, hubs, and patients at the point of care.
Closing that gap requires anticipating changes in access before they show up in utilization, not reacting after the fact.
Formulary positions can look unchanged while payers tighten the levers that matter at the point of care. Examples include tightening utilization management, shifting benefit design, changing site-of-care rules, or selectively applying controls. These changes can materially affect utilization and brand performance long before they surface in published policy.
Traditional access and shareshift models are effective at answering an important question: given a set of access conditions, how might share move? The challenge is that access conditions themselves are increasingly dynamic and often only understood after the fact.
To get ahead of access changes, manufacturers need an early-warning view of which payers are likely to move, how they will enforce, and when action is required.
Predictive access analytics turn early signals into a probability-based outlook, so teams can act before performance metrics force the conversation.
Most access analytics rely on declared policy, including formularies, tiers, UM rules, and coverage criteria as a proxy for access reality. While this context is necessary, these signals are incomplete.
Payers often enforce access differently than their published policy suggests.
Two products may share the same formulary position yet experience very different levels of friction at the point of care. Conversely, access can tighten materially even when policy language remains unchanged. These enforcement shifts are often first visible in claims behavior, not in policy updates.
When access changes are identified only after utilization has already moved, downstream forecasting and shareshift analyses become reactive rather than strategic.
Precision AQ’s Predictive Access Engine (PAE) forecasts how access is likely to change before those changes fully show up in utilization. It is built to help manufacturers identify payer-specific risk early and respond with the right actions.
PAE does not replace shareshift modeling. Instead, it strengthens it by improving the realism and timing of the access assumptions that underpin shareshift forecasts.
PAE is built on a practical distinction that market access teams deal with every day:
Together, these dimensions define effective access, meaning the access reality that drives utilization and share.
PAE shows what is driving the forecast, including the strongest signals and the closest historical analogs, so teams can challenge the output and use it in decisions.
PAE uses three inputs:
1. Market and Policy Events
Precision AQ’s PAE continuously tracks events that historically precede access change, such as:
These events are identified and monitored through Precision AQ’s proprietary intelligence infrastructure, which continuously synthesizes structured policy sources and unstructured public data to surface emerging access signals in near real time. They serve as potential triggers, not conclusions.
2. Analog Markets and Historical Patterns
Not all events are equal, and payer responses are rarely uniform.
Precision AQ’s PAE evaluates how similar events played out in analogous markets, controlling for factors such as therapeutic area dynamics, payer mix, competitive intensity, and historical enforcement behavior. This analog-based approach grounds predictions in observed reality rather than theoretical assumptions.
3. Claims-Based Enforcement Signals
Claims data provides an early window into how access is being applied at the point of care. Shifts in rejection rates, benefit steering, or utilization management intensity often emerge here before they are reflected in published policy.
By integrating these signals, Precision AQ’s PAE identifies where access is likely to tighten or loosen, and which payers are most likely to move first.
Shareshift models are only as strong as the access assumptions that feed them. By informing those assumptions with predictive access insight, PAE enables manufacturers to:
Importantly, PAE is not designed to forecast exact utilization outcomes in isolation. Its role is to improve decision-making under uncertainty by elevating access from a static input to a dynamic, forward-looking signal.
As payer behavior becomes more nuanced and enforcement-driven, the gap between declared policy and access reality continues to widen. Manufacturers that rely solely on backward-looking signals risk responding too late or misreading the drivers of share movement.
Predictive access analytics offers a way to close that gap by identifying changes in access while they are still forming, not after they have already reshaped utilization.
By systematically linking market events, historical analogs, and real-world enforcement signals, PAE helps manufacturers move from explaining what happened to anticipating what’s likely to happen next.
Access change is often subtle, and it can be easy to miss. Foresight is now a requirement for protecting performance.
Interested in learning more? To explore how predictive access insight can inform earlier, more confident access decisions, schedule a meeting with our team.